Femtolaser-assisted phaco offers advantages in patients with endothelial dystrophy

Femtolaser-assisted phaco offers advantages in patients with endothelial dystrophy
Leigh Spielberg
Leigh Spielberg
Published: Friday, September 23, 2016
euretina%ef%80%a2escrs-main_richard_1910“Because of frequent development or progression of cataract after vitrectomy for such indications as macular hole or epiretinal membrane, combining vitrectomy and phacoemulsification in one operation may be indicated, especially in elderly patients,” said Gisbert Richard MD, Germany. Speaking to a combined EURETINA/ESCRS session in Copenhagen yesterday, Dr Richard emphasized the difference between cataract progression in post-vitrectomy patients above the age of 60 years, in which the incidence approaches 100%, and those younger than 40 years, who have very low risk of cataract after vitrectomy.   “Phaco-vitrectomy has developed into a very safe and effective combined procedure which often improves visibility of the posterior segment during surgery, and also spares patients a second procedure later in time,” said Dr Richard.   Indeed, surgical time might not necessarily increase as compared to vitrectomy alone, as complete vitrectomy is technically simpler in a pseudophakic eye, due to the eliminated risk of lens touch during shaving of the vitreous base. Dr Richard recommends creating a long corneal or corneo-scleral tunnel that tolerates the intraocular pressure increases experienced during vitrectomy. “The tunnel should be at least 3.0mm,” he said.   “Femtolaser-assisted phaco can offer advantages in patients with endothelial dystrophy,” he added, although complicated technical equipment and additional costs might limit this development.   Dr Richard’s study of combined phaco-vitrectomy in 230 patients operated for epiretinal membrane indicated good visual outcome for what has since become routine procedure for many surgeons.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...